Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Genetic Regulation of Lipid Pathways Contributing to Non-alcoholic Fatty Liver and Atherogenic Dyslipidemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04209816
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:34.687263+00:00
Published At
2023-09-22T00:00:00+00:00
Record Updated At
2023-09-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Non-alcoholic Fatty Liver", "Atherogenic Dyslipidemia", "Insulin Resistance"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-09-22"
protocolSection.identificationModule.nctId
"NCT04209816"
protocolSection.identificationModule.officialTitle
"Genetic Regulation of Lipid Pathways Contributing to Non-alcoholic Fatty Liver and Atherogenic Dyslipidemia"
protocolSection.statusModule.overallStatus
"ENROLLING_BY_INVITATION"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Non-alcoholic Fatty Liver (protocolSection.conditionsModule.conditions)
  • Atherogenic Dyslipidemia (protocolSection.conditionsModule.conditions)
  • Insulin Resistance (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.